MJA
MJA InSight
MJA Careers
Letters

Inappropriate prescribing for osteoporosis

Ego Seeman, Mark A Kotowicz, Peter T Nash and Philip N Sambrook
Med J Aust 2009; 191 (6): 355-356.

To the Editor: Nordin and colleagues raised important issues about prescribing for osteoporosis.1 We agree that the Pharmaceutical Benefits Schedule guidelines for therapy are imperfect, but they do not necessarily lead, as Nordin et al claim, to inappropriate prescribing.

Ego Seeman, Past President,1 and Professor of Medicine and Endocrinologist2
Mark A Kotowicz, Councillor,1 and Associate Professor and Endocrinologist2
Peter T Nash, Councillor,1 and Associate Professor and Rheumatologist3
Philip N Sambrook, President,1 and Head and Director4
1 Australian and New Zealand Bone and Mineral Society, Sydney, NSW.
2 Department of Medicine, University of Melbourne, Melbourne, VIC.
3 School of Medicine, University of Queensland, Brisbane, QLD.
4 Institute of Bone and Joint Research, Royal North Shore Hospital, Sydney, NSW.
Article References: 
Reference Text: 
Nordin BEC, Horowitz M, Chatterton BE. Inappropriate prescribing for osteoporosis [letter]. Med J Aust 2009; 190: 519-520.
Reference Order: 
1
PubMed ID: 
19413534
Reference Text: 
Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int 2006; 17: 1726-1733.
Reference Order: 
2
PubMed ID: 
16983459
Reference Text: 
Royal Australian College of General Practitioners. Osteoporosis clinical guideline April 2008 draft. http://www.racgp.org.au/Content/NavigationMenu/ClinicalResources/RACGPGuidelines/Arthritis/OPguideline.pdf (accessed Aug 2009).
Reference Order: 
3
PubMed ID: 
Reference Text: 
Rose G. Sick individuals and sick populations. Int J Epidemiol 1985; 14: 32-38.
Reference Order: 
4
PubMed ID: 
3872850
Reference Text: 
MacLean C, Newberry S, Maglione M, et al. Systematic review: comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis. Ann Intern Med 2008; 148: 197-213.
Reference Order: 
5
PubMed ID: 
18087050
Reference Text: 
Seeman E, Devogelaer JP, Lorenc R, et al. Strontium ranelate reduces the risk of vertebral fractures in patients with osteopenia. J Bone Miner Res 2008; 23: 433-438.
Reference Order: 
6
PubMed ID: 
17997711
Reference Text: 
Eisman J, Clapham S, Kehoe L. Osteoporosis prevalence and levels of treatment in primary care: the Australian BoneCare Study. J Bone Miner Res 2004; 19: 1969-1975.
Reference Order: 
7
PubMed ID: 
15537439
Reference Text: 
Chen JS, Hogan JC, Lyubomirsky G, Sambrook PN. Management of osteoporosis in primary care in Australia. Osteoporos Int 2009; 20: 491-496.
Reference Order: 
8
PubMed ID: 
18633666

The full contents of this page are only available to subscribers.